|
|
||||||||
American Journal of Clinical Nutrition, Vol 61, 818-826, Copyright © 1995 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
DC Macallan, MA McNurlan, E Milne, AG Calder, PJ Garlick and GE Griffin
Department of Cellular and Molecular Sciences, St George's Hospital Medical School, London, UK.
Whole-body protein metabolism was investigated in human immunodeficiency virus (HIV) infection by primed constant infusion of L- [1-13C]leucine in 8 control and 22 HIV-infected subjects (8 stage II; 14 stage IV disease), in postabsorptive and fed states. Postabsorptive leucine flux was increased 25% in subjects with stage IV HiV infection vs that in control subjects (130 +/- 13 vs 103 +/- 10 mumol leucine.kg- 1.h-1, P < 0.001); both leucine disposal by protein synthesis (111.6 +/- 12.1 vs 82.3 +/- 9.2, P < 0.001) and release by protein degradation (129.7 +/- 13.1 vs 103.4 +/- 10.2, P < 0.001) were increased. No difference in leucine balance or oxidation was found but fat oxidation was greater in subjects with HIV infection (61.1 +/- 13.0% of energy) than in control subjects (47.6 +/- 13.7% of energy, P < 0.025). Stage II subjects had intermediate values of leucine flux, not significantly different from those of control subjects. Provision of parenteral nutrition for 4 h increased leucine flux with a switch in leucine balance from net loss to net gain; this response was quantitatively similar in all groups. HIV infection increases whole-body protein turnover but does not quantitatively impair the acute anabolic response to intravenous nutrition.
This article has been cited by other articles:
![]() |
F. R Sattler, N. Rajicic, K. Mulligan, K. E Yarasheski, S. L Koletar, A. Zolopa, B. Alston Smith, R. Zackin, B. Bistrian, and for the ACTG 392 Study Team Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1313 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Reeds, W. T. Cade, B. W. Patterson, W. G. Powderly, S. Klein, and K. E. Yarasheski Whole-Body Proteolysis Rate Is Elevated in HIV-Associated Insulin Resistance. Diabetes, October 1, 2006; 55(10): 2849 - 2855. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Toth and D. E. Matthews Whole-Body Protein Metabolism in Chronic Heart Failure: Relationship to Anabolic and Catabolic Hormones JPEN J Parenter Enteral Nutr, May 1, 2006; 30(3): 194 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Prod'homme, C. Rochon, M. Balage, H. Laurichesse, I. Tauveron, C. Champredon, P. Thieblot, J. Beytout, and J. Grizard Whole body leucine flux in HIV-infected patients treated with or without protease inhibitors Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E685 - E693. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Yarasheski, S. R. Smith, and W. G. Powderly Reducing plasma HIV RNA improves muscle amino acid metabolism Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E278 - E284. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Crenn, B. Rakotoanbinina, J.-J. Raynaud, F. Thuillier, B. Messing, and J.-C. Melchior Hyperphagia Contributes to the Normal Body Composition and Protein-Energy Balance in HIV-Infected Asymptomatic Men J. Nutr., September 1, 2004; 134(9): 2301 - 2306. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. I Paton, Y.-M. Ng, C. B. Chee, C. Persaud, and A. A Jackson Effects of tuberculosis and HIV infection on whole-body protein metabolism during feeding, measured by the [15N]glycine method Am. J. Clinical Nutrition, August 1, 2003; 78(2): 319 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jahoor, S. Abramson, and W. C Heird The protein metabolic response to HIV infection in young children Am. J. Clinical Nutrition, July 1, 2003; 78(1): 182 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Williams, G. Bartsch, N. Muurahainen, G. Collins, S. S. Raghavan, and D. Wheeler Protein Intake Is Positively Associated with Body Cell Mass in Weight-Stable HIV-Infected Men J. Nutr., April 1, 2003; 133(4): 1143 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Kotler Cachexia Ann Intern Med, October 17, 2000; 133(8): 622 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. K. J. ENGELEN, N. E. P. DEUTZ, E. F. M. WOUTERS, and A. M. W. J. SCHOLS Enhanced Levels of Whole-body Protein Turnover in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1488 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
F X. Pi-Sunyer Overnutrition and undernutrition as modifiers of metabolic processes in disease states Am. J. Clinical Nutrition, August 1, 2000; 72(2): 533S - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jahoor, B. Gazzard, G. Phillips, D. Sharpstone, M. Delrosario, M. E. Frazer, W. Heird, R. Smith, and A. Jackson The acute-phase protein response to human immunodeficiency virus infection in human subjects Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1092 - E1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Sattler, S. V. Jaque, E. T. Schroeder, C. Olson, M. P. Dube, C. Martinez, W. Briggs, R. Horton, and S. Azen Effects of Pharmacological Doses of Nandrolone Decanoate and Progressive Resistance Training in Immunodeficient Patients Infected with Human Immunodeficiency Virus J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1268 - 1276. [Abstract] [Full Text] |
||||
![]() |
K. E. Yarasheski, J. J. Zachwieja, J. Gischler, J. Crowley, M. M. Horgan, and W. G. Powderly Increased plasma Gln and Leu Ra and inappropriately low muscle protein synthesis rate in AIDS wasting Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E577 - E583. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Laurichesse, I. Tauveron, F. Gourdon, L. Cormerais,, C. Champredon, S. Charrier, C. Rochon, S. Lamain,, G. Bayle, H. Laveran, et al. Threonine and Methionine Are Limiting Amino Acids for Protein Synthesis in Patients with AIDS J. Nutr., August 1, 1998; 128(8): 1342 - 1348. [Abstract] [Full Text] |
||||
![]() |
K. Mulligan, V. W. Tai, and M. Schambelan Effects of Chronic Growth Hormone Treatment on Energy Intake and Resting Energy Metabolism in Patients with Human Immunodeficiency Virus-Associated Wasting--A Clinical Research Center Study J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1542 - 1547. [Abstract] [Full Text] |
||||
![]() |
K. Berneis, R. Ninnis, J. Girard, B. M. Frey, and U. Keller Effects of Insulin-Like Growth Factor I Combined with Growth Hormone on Glucocorticoid-Induced Whole-Body Protein Catabolism in Man J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2528 - 2534. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Macallan, C. Noble, C. Baldwin, S. A. Jebb, A. M. Prentice, W. A. Coward, M. B. Sawyer, T. J. McManus, and G. E. Griffin Energy Expenditure and Wasting in Human Immunodeficiency Virus Infection N. Engl. J. Med., July 13, 1995; 333(2): 83 - 88. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |